AngioDynamics, Inc. Forecast, price target & analysts
AngioDynamics, Inc. Target price 2025 - Analyst rating & recommendation
AngioDynamics, Inc. Classifications & Recommendation:
AngioDynamics, Inc. Price Target
| Target Price | $16.83 |
| Price | $8.45 |
| Potential |
99.17%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target AngioDynamics, Inc. 2026 .
The average AngioDynamics, Inc. target price is $16.83.
This is
99.17%
register free of charge
$25.20
198.22%
register free of charge
$16.16
91.24%
register free of charge
|
|
| A rating was issued by 10 analysts: 9 Analysts recommend AngioDynamics, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the AngioDynamics, Inc. stock has an average upside potential 2026 of
99.17%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2029
| May '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 292.50 | 313.34 |
| 3.75% | 7.12% | |
| EBITDA Margin | -4.79% | 1.74% |
| 31.39% | 136.30% | |
| Net Margin | -11.62% | -3.02% |
| 80.84% | 74.01% |
6 Analysts have issued a sales forecast AngioDynamics, Inc. 2026 . The average AngioDynamics, Inc. sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an AngioDynamics, Inc. EBITDA forecast 2026. The average AngioDynamics, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 AngioDynamics, Inc. Analysts have issued a net profit forecast 2026. The average AngioDynamics, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2029
| May '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.83 | -0.23 |
| 81.92% | 72.29% | |
| P/E | negative | |
| EV/Sales | 0.94 |
5 Analysts have issued a AngioDynamics, Inc. forecast for earnings per share. The average AngioDynamics, Inc. EPS is
This results in the following potential growth metrics and future valuations:
AngioDynamics, Inc....
Current AngioDynamics, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Jul 16 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jul 16 2025 |
| Lake Street |
Locked
➜
Locked
|
Locked | Jul 16 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 07 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 10 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Dec 10 2024 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Oct 04 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Jul 16 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jul 16 2025 |
|
Locked
Lake Street:
Locked
➜
Locked
|
Jul 16 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 07 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 10 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Dec 10 2024 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Oct 04 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
